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Abstract
Our previous study demonstrated that 60 % ethanol crude extract of Sambucus williamsii HANCE (SWH) improved bone mass, bone
strength and bone micro-structure in both ovariectomised (OVX) rats and mice. The present study aims to identify the bioactive fractions
and ingredients in SWH that account for its osteoprotective effects. Bilateral sham-operated mice acted as controls. OVX C57BL/6J mice,
aged 12 weeks, were orally administrated daily with vehicle or 17b-oestradiol (3·2 mg/kg), SWH (60 % ethanol crude extract; 1·0 g/kg), SWA
(water eluate; 0·570 g/kg), SWB (30 % ethanol eluate; 0·128 g/kg) or SWC (50 and 95 % ethanol eluates; 0·189 g/kg) for 12 weeks. The
effects of the different fractions on bone properties in the OVX mice model were studied. In addition, their effects on osteoblast prolifer-
ation and differentiation were evaluated in UMR 106 cells. SWC significantly restored bone mineral density and improved bone size and
bone content parameters in the femur and tibia as well as increased biomechanical strength at the tibia diaphysis in OVX mice. Similarly,
SWC was the most potent fraction in stimulating cell proliferation and differentiation in UMR 106 cells. Also, SWC did not alter uterus
weight in OVX mice. Nine major peaks, seven lignans and two phenolic acids, in the HPLC fingerprint of the SWC fraction were identified,
isolated and characterised. In conclusion, the present study demonstrated that SWC was the most potent fraction in SWH that exerted anti-
osteoporotic effects. Furthermore, lignans might be the potential bioactive components in SWC.
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Osteoporosis is a skeletal disorder of reduced bone mass and
disruption of bone architecture with a consequent increase in
bone fragility and fracture risk(1). The decline of gonadal func-
tion following menopause and ageing plays a key role in the
pathogenesis of osteoporosis. With a worldwide increase in
ageing populations, osteoporosis has become a more serious
global health problem. Hormone replacement therapy was a
routine method to alleviate physical symptoms and to prevent
the clinical consequence of postmenopausal osteoporosis(2).
However, recent studies suggest that hormone replacement
therapy is associated with an increased risk of developing
breast, ovarian and endometrial cancers(3–6). This has led to
increased interest in identifying natural oestrogen analogues
that possess osteoprotective effects without any side effects
on reproductive tissues. A class of plant-derived substances,
the so-called ‘phyto-oestrogens’, has been reported to possess
structures similar to mammalian oestrogens and display
both oestrogenic and anti-estrogenic effects(7–8). Isoflavones,
lignans and cumestans are the major classes of phyto-
oestrogen(7). Numerous studies on isoflavones in preventing
the loss of bone mineral density (BMD) have been
reported(9,10), while those that focus on the bone-protective
effects of lignans and cumestans are few.
Sambucus williamsii HANCE (SWH), one species of
Sambucus distributed in various regions of China, Korea and
Japan, has been used as a folk medicine to treat bone and
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joint diseases in China for thousands of years(11). Our previous
study showed that the ethanol extract of SWH had protective
effects on trabecular bone and cortical bone(12) and the mech-
anisms included stimulation of osteoblast differentiation, inhi-
bition of osteoclastogenesis as well as osteoclast actions(13).
Moreover, lignans(14), phenolic acids(15), triterpenoids(16) and
some other compounds had been isolated from the ethanol
extract of SWH. However, it is unclear which of the ingre-
dients in SWH are responsible for its bone-protective actions.
In the present study, both in vivo and in vitro models were
employed to identify the active fractions and ingredients in
SWH that account for its bone-protective actions. The bio-
activities of fractions prepared from the ethanol extract of
SWH using a macroporous adsorption resin column were
determined. The HPLC fingerprint of the bioactive fraction
was established and the major components were characterised.
Materials and methods
Plant materials and isolation
The stems and branches of SWH were collected in Shenyang,
Liaoning Province in the northeast of China in April 2007 and
authenticated according to a method listed in the Chinese
Bencao(17) with the help of Professor Zerong Jiang (Shenyang
Pharmaceutical University in Shenyang, China). The identity of
SWH was confirmed by analysing its major ingredients pen-
tacylic triterpenoid, phenol acid and derivatives and protein.
A voucher specimen (HHXSWGZ-2007) was deposited in the
Herbarium of the Institute of Traditional Chinese Medicine
and Natural Products (Jinan University, Guangzhou, China).
Dry stems and branches of SWH (50 kg) were refluxed with
500 litres of 60 % (v/v) ethanol three times, for 2 h each time.
After filtration, the filtrate was concentrated under reduced
pressure and then freeze-dried to obtain a total extract of
1·25 kg powder. As shown in Table 1, SWH (1250 g) was
applied to a D-101 macroporous adsorptive resin column
(diameter 8·0 cm £ height 96 cm), eluted with water and etha-
nol in gradient, to give SWA (water eluate; 712·5 g), SWB (30 %
ethanol eluate; 160·0 g) and SWC (50 and 95 % ethanol eluates;
236·0 g). The 50 and 95 % ethanol eluates were combined to
give SWC after HPLC analysis because both fractions contain
similar constituents and because the yield of the 95 % ethanol
eluate was too low. The HPLC fingerprint of SWC was
established using the Agilent series 1200 HPLC system (Agilent
Technologies, Santa Clara, CA, USA): a reversed-phase (RP)-
HPLC column (Welch XB-C18, 4·60 £ 250 mm; Welch Mate-
rial, Shanghai, China) with a gradient of methanol–water
(0·1 % acetic acid) as the mobile phase (0–9 min, 25 %; 9–
39 min, 36 %; 39–54 min, 50 %; 54–59 min, 100 %), at a flow
rate of 0·8 ml/min. Detection wavelength was at 280 nm and
column temperature was at 358C. The major peaks of the fin-
gerprint were characterised with the compounds isolated from
SWC using the same HPLC conditions.
Animal study
A total of fifty-six virgin C57BL/6J specific-pathogen-free (SPF)
female mice, aged 12 weeks, were purchased from Laboratory
Animal Services Centre (Chinese University of Hong Kong,
Hong Kong, China) and housed in cages under a 12 h
light–12 h dark cycle at 20 ^ 18C. During the study, all ani-
mals were allowed free access to distilled deionised water,
and OVX mice were pair-fed a phyto-oestrogen-free diet
(D00031602; Research Diets, Inc., New Brunswick, NJ, USA)
(Table 2) based on the average daily food consumption of
the sham control group.
The mice were either sham-operated (Sham, n 8) or ovari-
ectomised (OVX, n 48). The treatment dose of each fraction
was deduced from the yield. The OVX mice were randomly
divided into six groups: vehicle-treated group (OVX, n 8);
17b-oestradiol administration group (E2; n 8; 3·2mg/g body
weight per d); SWH (ethanol extract group; n 8; 1·0 mg/g
body weight per d); SWA (water eluate group; n 8;
0·570 mg/g body weight per d), SWB (30 % ethanol eluate
Table 1. The fractions of Sambucus williamsii HANCE* and their yield
Fraction
Isolated solvent (v/v)
Isolated
content (g)
Percentage
of total crude
extract (%)
Ethanol
(%)
Water
(%)
SWA 0 100 712·5 57·0
SWB 30 70 160·0 12·8
SWC† 50 50 224·2 13·9
95 5 11·8 5·0
* The ethanol extract of Sambucus williamsii HANCE (1250 g) was applied to a
D-101 macroporous adsorptive resin column (diameter 8·0 cm £ height 96 cm),
and eluted with water and ethanol in gradient to give its fractions.
† The 50 % ethanol eluate and 95 % ethanol eluate were combined together to
give SWC.
Table 2. Formulations and estimated nutrient composition
of experimental diets
Nutrient
Diet (D00031602)
(g/kg diet)
Total energy (kJ/kg) 16 119·2
Protein 142·0
Carbohydrate 731·0
Fat 40·0
Soyabean oil 0
Maize oil 40·0
t-Butylhydroquinone 0·008
Mineral mix S10022G* 35·0
Vitamin mix V10037† 10·0
Choline bitartrate 2·5
Casein 140·0
L-Cystine 1·8
Maize starch 495·7
Maltodextrin 10 125·0
Sucrose 100·0
Cellulose, BW200 50·0
* The mineral mix composition was as follows (amount in 35 g):
5·0 g Ca, 2·0 g P, 0·5 g Mg, 3·6 g K, 0·3 g S, 1·0 g Na, 1·6 g Cl,
6·0 mg Cu, 0·2 mg I, 45 mg Fe, 10·5 mg Mn, 0·2 mg Se and
30·0 mg Zn.
† The vitamin mixture composition was as follows (amount in 10 g):
2·2 mg vitamin A (all-trans-retinyl palmitate), 25mg cholecalci-
ferol, 33·75 mg vitamin E (all-rac-a-tocopheryl acetate), 0·75 mg
phylloquinone, 0·2 mg biotin, 25mg cyanocobalamin, 2 mg folic
acid, 30 mg nicotinic acid, 16 mg calcium pantothenate, 7 mg
pyridoxine-HCl, 6 mg riboflavin, 6 mg thiamin HCl.
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group; n 8; 0·128 mg/g body weight per d); SWC (50 and 95 %
ethanol eluates group; n 8; 0·189 mg/g body weight per d).
The solutions of SWH and its fractions were freshly prepared
as SWH (100 mg/ml), SWA (57 mg/ml), SWB (12·8 mg/ml)
and SWC (18·9 mg/ml), and were given daily to mice. A phyto-
oestrogen-free diet was applied in the present study to
eliminate interactions between diet and fractions of SWH
that had been reported in our previous study(13). Drug treat-
ment started 2 weeks after the surgery and was administrated
orally through a gastric tube for 3 months. At the end of the
treatment, the mice were killed, blood was withdrawn from
the abdominal aorta and serum was prepared. From each
animal, the uterus was collected, weighed and then stored at
2808C. The left femur and tibia were dissected and cleaned
of all soft tissue, then wrapped in gauze saturated with PBS
buffer, sealed in Eppendorf tubes and stored at 2208C for
further analysis. The animal study protocols were approved
by the Animal Ethics Committee of The Hong Kong Poly-
technic University.
Micro-computed tomography analysis of bone properties
The distal metaphysis of femur and the proximal metaphysis
of tibia were scanned with a high-resolution micro vivaCT
40 system (Scanco Medical, Bassersdorf, Switzerland). The
distal and proximal site was defined as 2·0 mm away from
the femur end and tibia head. After images were captured,
twenty out of 100 slices were chosen and established as the
volume of interest. Trabecular bone was separated from corti-
cal bone by free drawing regions using the software provided
with the scanner. Then three-dimensional (3D) modelling
was generated and morphological date of the sample was
evaluated using a script-based 3D volume analysis tool IPL
(Image Processing Language; Scanco Medical; http://www.
scanco.ch/systems-solutions/software.html). 3D parameters
for trabecular bone were obtained as follows: (1) bone
volume/tissue volume (BV/TV); (2) trabecular bone number
(Tb.N); (3) trabecular bone separation (Tb.Sp); (4) BMD.
Three-point bending test
The left tibias were cleaned to remove their surrounding soft
tissue before the test. A three-point bending machine
(model H10KM; Hounsfield Test Equipment Limited, Redhill,
Surrey, UK) was used to determine the mechanical strength
on the mid-shaft of the left tibia(18). The two supporting
points were fixed 4 mm apart with a single central loading
point. A load was applied on the mid-shaft with a deformation
rate of 2·0 mm/min and a load–deformation curve was plotted
simultaneously until the specimen was broken. Bending
stiffness was calculated as the slope of the linear part of the
loading–deformation curve.
Cell culture
UMR 106 cells were cultured in Dulbecco’s modified Eagle’s
medium with 10 % fetal bovine serum, which was pre-
supplemented with penicillin (100 units/ml) and streptomycin
(100 mg/ml). At 80–90 % confluence, the cells were seeded in
a ninety-six-well microtitre plate with 4000 cells/well. After
incubation for 48 h, the culture medium was changed to
phenol red-free Dulbecco’s modified Eagle’s medium with
1 % charcoal-stripped fetal bovine serum for 24 h. The cells
were then treated with SWH fractions at 0·1, 1·0, 10 or
100mg/ml for 24 or 48 h. The cells were cultured at 378C in
a humidified atmosphere of 95 % air and 5 % CO2.
Cell proliferation assay
The proliferation effects of the fractions of SWH on the UMR
106 cell line were determined by the MTS colorimetric assay.
After treating with SWH fractions (0·1 to 100mg/ml) or vehicle
for 24 h or 48 h, the medium was removed, followed by
the addition of 0·2 mg/ml 3-(4,5-dimethylthiazol-2-yl)-5-(3-car-
boxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS;
Promega Corp., Madison, WI, USA) and 1 mg/ml phenazine
methosulfate (PMS; Sigma-Aldrich, St Louis, MO, USA) reagent.
The absorbance was detected on a microplate spectro-
photometer (model 680; Bio-Rad, Hercules, CA, USA) at a wave-
length of 490 nm after 2 h of incubation at 378C.
Alkaline phosphatase activity assay
Alkaline phosphatase activity of the treated cells was deter-
mined by the hydrolysis of p-nitrophenylphosphate (Promega
Corp.) to p-nitrophenol to assess the differentiation activity
of UMR 106 cells. The treated cells were rinsed with PBS
twice before 100ml p-nitrophenylphosphate were added to
them. Absorbance of the tested samples was measured
at 405 nm. All results are expressed as a ratio normalised to
the corresponding total protein content (optical density at
405 nm/mg BSA).
Statistical analysis
The data from these experiments are reported as mean values
with their standard errors for each group. All statistical
analyses were performed using PRISM version 5.0 (GraphPad,
San Diego, CA, USA). Inter-group differences were analysed
by one-way ANOVA, and followed by Tukey’s multiple-
comparison test as a post hoc test to compare the group
mean if overall P,0·05. Differences of P,0·05 were
considered statistically significant.
Results
Body weight, uterine weight and serum biochemical
makers
The effects of SWH fractions on body weight, uterus index and
serum biochemical makers are summarised in Supplemen-
tary Appendix 1 (available online at http://www.journals.
cambridge.org/bjn). As expected, body weight increased
significantly (P,0·05) and uterus index decreased significantly
(P,0·05) in OVX mice as a result of oestrogen deficiency.
Treatment of OVX mice with SWH or SWC extracts significantly
H.-H. Xiao et al.1804
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suppressed oestrogen deficiency-induced body-weight gain
(v. OVX group, both P,0·001). Uterus indexes were
significantly increased in OVX mice in response to treatment
with E2 or SWH. However, uterus indexes of the mice treated
with the fractions of SWH did not alter as compared with those
treated with vehicle. Serum Ca level and P levels were not
altered by OVX or fractions of SWH.
Micro-computed tomography analysis of left femur and
tibia
As shown in Table 3, ovariectomy significantly reduced BMD
at the distal metaphysis of femur (P,0·05 v. sham) and the
proximal metaphysis of tibia (P,0·05 v. sham) in mice. Treat-
ment of OVX mice with E2 prevented the decrease in BMD at
both sites (P,0·001 v. OVX). Similarly, treatment of OVX mice
with SWH or SWC significantly restored BMD at the femur and
tibia. Trabecular bone microstructure, as indicated by para-
meters such as BV/TV, Tb.N and Tb.Sp at the distal metaphysis
of femur and at the proximal metaphysis of tibia deteriorated
significantly in mice upon ovariectomy (Table 3; P,0·05 in all
parameters at both sites). The damage of bone microstructure
induced by ovariectomy in mice at the femur were reversed
significantly by treatment with SWH (P,0·01 in BV/TV),
SWA (P,0·05 in BV/TV) or SWC (P,0·01 in BV/TV, P,0·01
in Tb.N and P,0·05 in Tb.Sp) and at the tibia by treatment
with SWH (P,0·001 in BV/TV, P,0·05 in Tb.N and P,0·01
in Tb.Sp) or SWC (P,0·001 in BV/TV, P,0·05 in Tb.N and
P,0·01 in Tb.Sp). Among all the fractions of SWH, the
bone-protective effect of SWC was the same as or even
higher than that of the total ethanol extract SWH. There
were no differences of the trabecular bone parameters
between Sham and the fraction-treated groups. The adminis-
tration of SWH fractions restored the bone loss induced by
ovariectomy to the normal level and maintained the micro-
architecture of trabecular bone.
Biomechanical measurement of left tibia
Table 4 shows the effects of SWH fractions on the biomecha-
nical properties of the left tibia in OVX mice. Three-point
bending experiments indicated that treatment of OVX mice
with E2 significantly increased the ultimate load (P,0·001),
breaking force (P,0·05) as well as stiffness (P,0·05) of the
tibia mid-shaft. Ultimate load of the left tibia mid-shaft were
significantly increased in OVX mice in response to treatment
with different SWH fractions, namely SWA (P,0·05), SWB
(P,0·05) and SWC (P,0·01). Breaking forces of the left
tibia mid-shaft were increased significantly in OVX mice in
response to treatment with SWC (P,0·01) while treatment
with SWH did not show such effects on the breaking force.
Stiffness of the tibia was only increased in OVX mice in
response to treatment with SWA (P,0·05). Treatment of
OVX mice with SWH fractions suppressed the OVX-induced
reduction of ultimate load and stiffness in the tibia, resulting
in an increase back to the Sham level. However, E2 and all
fractions of SWH had no significant effects on changes of
energy of breaking. T
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Rat osteoblast-like UMR 106 cell proliferation and
differentiation assay
Fig. 1(a) shows that treatment of rat osteoblast-like UMR 106
cells with SWH at 1mg/ml for 24 and 48 h significantly
increased cell proliferation (P#0·001). The stimulatory effects
of SWA, SWB and SWC (Fig. 1(b), (c), (d)) on UMR 106 cell
proliferation were more potent than the effects of SWH
(Fig. 1(a)). Treatment of UMR 106 cells with 0·1 to 100mg/ml
of SWA (Fig. 1(b)) or SWC (Fig. 1(d)) for 24 or 48 h significantly
increased cell proliferation at all concentrations. SWB at 10 or
100mg/ml (Fig. 1(c)) significantly increased UMR 106 cell pro-
liferation. To determine the effects of different SWH extracts
on osteoblastic cell differentiation, alkaline phosphatase activi-
ties in UMR 106 cells in response to different concentrations of
SWH, SWA, SWB and SWC were measured. As observed with
E2, SWH (Fig. 2(a)) and SWB (Fig. 2(c)) significantly promoted
cell differentiation activity at 0·1mg/ml (both P,0·05), while
SWA (Fig. 2(b)) had no effects on cell differentiation. SWC
(Fig. 2(d)) significantly increased cell alkaline phosphatase
activity at all concentrations (0·1 to 100mg/ml), especially at
1mg/ml (122·8 %), which was higher than the increased level
upon treatment with E2 (112·4 %).
Identification of components in Sambucus williamsii
HANCE 50 and 95% ethanol eluate
The peaks of the HPLC fingerprint of SWC (Supplementary
Appendix 2; available online at http://www.journals.
cambridge.org/bjn) characterised with the compounds iso-
lated from SWC were as follows: peak 1 (16·8 min, vanillic
acid); peak 2 (22·7 min, coniferyl alcohol); peak 3 (28·3 min,
(þ)-erythro-1-(4-hydroxy-3-methoxyphenyl)-2-[4-(3-hydroxy-
propanyl)-2-methoxy-phenoxy]-1, 3-propanediol); peak 4
(29·3 min, (þ)-thero-1-(4-hydroxy-3-methoxyphenyl)-2-[4-(3-
hydroxypropanyl)-2-hydro-phenoxy]-1,3-propanediol);peak5
(29·9 min, (þ)-thero-guaiacylglycerol-b-O-40-conifery ether);
peak 6 (31·0 min, (þ)-erythro-1-(4-hydroxy-3-methoxy-
phenyl)-2-[-4-(3-hydroxypropanyl)-2-methoxy-phenoxy]-1,3-
propanediol); peak 7 (40·4 min, (þ )-lariciresinol); peak 8
(42·1 min, dehydrodiconiferylalcohol); peak 9 (42·8 min,
dihydrodehydrodiconiferyl alcohol). The sum of peak areas
of peaks 1 to 9 occupied 87·0 % of the total peak areas.
Discussion
The present study systematically evaluated the osteoprotective
effects of different fractions of SWH in OVX mice and in rat
osteoblast-like UMR 106 cells. The present results clearly
demonstrated that the 50 and 95 % ethanol eluates (SWC) of
the ethanol extract of SWH suppressed OVX-induced loss in
bone mass and bone strength and increase in body weight.
Besides, SWC did not alter the uterus weight in OVX mice.
Moreover, the present study showed that SWC effectively
promoted proliferation and differentiation in UMR 106 cells.
In addition, the present study identified that the major
components isolated from SWC were lignans, which may
account for the osteoprotective effects of this fraction or
even this herb.
Our recent study(13) reported that a 60 % ethanol extract of
SWH dose-dependently increased BMD but only a high-dose
treatment group showed statistically significant differences
compared with OVX mice. To investigate if further fractions
of SWH may lead to more potent protective effects in
bone, SWH was separated with a macroporous adsorptive
resin column and three fractions were obtained. The bone-
protective effects of the fractions and SWH were evaluated
and were compared using in vivo and in vitro results.
Trabecular bone mass, trabecular bone microstructure and
cortical bone biomechanical strength are three key aspects
associated with bone properties and turnover(19). Micro-com-
puted tomography measurement showed that SWH improved
trabecular BMD and suppressed disruption of trabecular
bone microstructure of the femur and tibia in OVX mice,
Table 4. Effects of Sambucus williamsii HANCE fractions on biomechanical properties of the left tibia
in ovariectomised mice
(Mean values with their standard errors)
Ultimate
load (N)
Breaking
force (N)
Energy for breaking
( £ 1023 J)
Stiffness
(N/mm)
Treatment‡ Mean SEM Mean SEM Mean SEM Mean SEM
Sham 20·83 0·87 18·57 0·59 9·82 0·67 54·31 3·14
OVX 17·93† 0·48 15·60† 0·56 9·06 0·78 36·10† 3·23
E2 23·27*** 0·81 19·74* 0·87 10·20 1·12 69·00* 9·43
SWH 19·95 0·47 17·60 0·56 9·89 0·60 61·48 7·94
SWA 20·90* 0·76 17·51 0·74 9·10 0·98 69·21* 7·57
SWB 20·97* 0·53 17·48 1·15 9·57 1·31 59·40 5·69
SWC 21·81** 0·82 19·72** 1·16 9·22 0·88 61·63 10·15
Sham, sham-operated, vehicle-treated; OVX, ovariectomised, vehicle-treated; E2, 17b-oestradiol (3·2mg/g body
weight per d); SWH, Sambucus williamsii HANCE ethanol extract (1·0 mg/g body weight per d); SWA, SWH water
eluate (0·570 mg/g body weight per d), SWB, SWH 30 % ethanol eluate (0·128 mg/g body weight per d); SWC,
SWH 50 and 95 % ethanol eluates (0·189 mg/g body weight per d).
Mean value was significantly different from that of the OVX group: *P,0·05, **P,0·01, ***P,0·001.
Mean value was significantly different from that of the Sham group: †P,0·05.
‡ Mice were subjected to the treatment for 12 weeks.
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a result that is in accordance with our previous study(12,13).
The fractions obtained from further fractionations of SWH
(i.e. SWA and SWC) did inhibit bone mineral loss induced
by ovariectomy. In particular, the protective effects of SWC
on trabecular bone in OVX mice were comparable with the
effects of SWH. Moreover, micro-architectural parameters
such as BV/TV, Tb.N and Tb.Sp of trabecular bone at the
distal metaphysis of femur and the proximal metaphysis of
tibia in OVX mice were significantly improved by treatment
with SWC and the improvement was even higher than brought
about by SWH. The results of three-point bending experi-
ments on tibial cortical bone demonstrated that all fractions
of SWH could significantly increase the ultimate load of the
tibia diaphysis. Furthermore, the SWC treatment significantly
increased breaking force and SWA treatment significantly
increased stiffness in OVX mice. These results indicated that
all fractions of SWH significantly improved the biomecha-
nical strength of the long bone in OVX mice. The analysis of
micro-computed tomography and three-point bending tests
suggested that SWC may contain nearly all (87 %) of the
active ingredients of SWH that account for its protective effects
on bone mass and bone quality.
SWH extract inhibited bone resorption by suppressing
osteoclastogenesis via modulation of the osteoprotegerin:
receptor activator of NF-kB ligand (OPG:RANKL) ratio in
UMR 106 cells(12). To investigate the effects of different SWH
fractions on osteoblastic cell function, the proliferation and
differentiation of osteoblast-like UMR 106 cells were deter-
mined in the present study. The studies showed that SWH
promoted cell proliferation and differentiation at 1 and
0·1mg/ml, respectively. Fractions obtained from further frac-
tionation of SWH stimulated osteoblastic cell proliferation
and differentiation. Among the fractions, SWC showed very
high potency for increasing cell proliferation and differen-
tiation at doses from 0·1 to 100mg/ml. Our in vitro results
confirmed the conclusion of the in vivo experiment that
SWC was the fraction with the highest potency on bone pro-
tection and was enriched with most of the active ingredients
in SWH that account for its ability to improve bone properties.
Our previous study found that the most effective dose
(1000 mg/kg) of ethanol extract of SWH after conversion
from animal to human dosage was 5·5 g/d in women with a
body weight of 50 kg(13). Similarly, the treatment dose of
SWC (0·189 g/kg) applied in the present study for the
improvement of bone properties will be 1·0 g/d for postmeno-
pausal women administered orally. The present finding
revealed that a lower dose of SWC will be needed to obtain
effects that are similar to or even better than SWH.
Oestrogen or substances with oestrogenic potential were
previously shown to be able to attenuate ovariectomy-induced
weight gain(19–21). The present results showed that SWH and
SWC significantly suppressed the body-weight gain induced
by OVX, suggesting that SWH and SWC might also contain
phyto-oestrogens. Similar to our previous study(13), the pre-
sent study confirmed that SWH stimulated the increase of
uterus weight in OVX animals. In contrast to SWH, SWC did
not alter uterus weight in OVX mice, suggesting that SWC
did not exert undesirable oestrogen-like effects on the
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Fig. 1. Effects of (a) Sambucus williamsii HANCE (SWH), (b) Sambucus
williamsii HANCE water eluate (SWA), (c) Sambucus williamsii HANCE 30 %
ethanol eluate (SWB) and (d) Sambucus williamsii HANCE 50 and 95 %
ethanol eluates (SWC) on cell proliferation in rat osteoblast-like UMR 106
cells. ( ), 24 h; ( ), 48 h; OD, optical density. Results were obtained from
three independent experiments. Values are means, with standard errors
represented by vertical bars. Mean value was significantly different from that
of the control (24 h): **P,0·01, ***P,0·001. Mean value was significantly
different from that of the control (48 h): †† P,0·01, ††† P,0·001.
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reproductive system. Rachon´ et al.(19–21) found that daidzein
and purarin at high doses (1·0 and 3·0 g/kg, respectively)
exerted uterotropic effects on OVX rats. Our studies provide
an exciting result for finding a new agent for bone protection
without unsatisfactory effects on the uterus.
Phenolic acids(15), lignans(14,22), triterpenoids(16) and some
other compounds had been isolated from SWH in our previous
study. However, the major active ingredients that account for
its bone protection in vivo are still not known. In the present
study, seven lignans and two phenolic acids, which are the
major components in SWC, were identified. The results
indicated that lignans might be the active ingredients in the
SWH fraction that account for its bone-protective effects
in vivo. However, the biological activities of these isolated
compounds were been studied in the present investigation.
Further study will be needed to confirm if these compounds
can directly stimulate the growth and differentiation of bone
cells as well as exert osteoprotective effects in vivo.
In conclusion, the present study revealed that SWC was the
fraction of highest potency in SWH and that it could prevent
bone loss, improve trabecular bone microstructure and
increase cortical bone strength in OVX mice. Most importantly,
the doses of SWC used in the present study can fully restore
bone loss to the pre-OVX level. The in vitro experiments
suggested that SWC might increase bone formation by pro-
moting proliferation and differentiation of osteoblast-like
cells. Most importantly, the effective dose of SWC to achieve
similar bone-protective effects as SWH is found to be only
one fifth of that of SWH. In addition, seven lignans and
two phenolic acids, which are the major peaks of the HPLC
fingerprint of SWC, were identified. Further studies are
needed to characterise the mechanism by which the isolated
lignans and phenolic acids exert anabolic effects on bone
cells, presumably osteoblasts. The present study suggests
that SWC needs to be investigated as a natural alternative for
the management of postmenopausal osteoporosis.
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